Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ITOS will decline by -0.25% over the next 2 Weeks and hit $10.12 by Thursday, September 11, 2025. In that time frame, ITOS's share price is expected to range between $9.93 and $10.29.
BearishAverageBullishITOS shares rose +0.20% in Friday, August 29, 2025's trading session, rising from a previous close of $10.13 to move at $10.15. The stock demonstrated notable intraday movement (see ITOS's key stats for a full breakdown), fluctuating between $10.15 and $10.15, a 0 trading range. While recent weeks have seen some volatility, ITOS has managed to secure a +0.40% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 10.94M shares changing hands, 8.35M more than the previous session. This amounted to $111.06M in total market activity.
Will ITOS Continue Its Upward Trend?
According to analyst ratings and projections for ITOS, iTeos Therapeutics, Inc. shares are anticipated to increase by +1.19%, potentially reaching $10.27 per share by September 11, 2025. Short-term technical indicators currently suggest a neutral sentiment for ITOS. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the ITOS stock forecast, now is a good time to buy ITOS stock because its current trading price is +0.49% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ITOS covering social and institutional perspectives.
ITOS Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ITOS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 53.04% to 57.82%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 57.42%, suggests a neutral medium-term outlook. However, the 100-day RSI, at 52.40%, maintains a neutral outlook for the long term. Insights into ITOS's shareholder base show how institutional investors are positioning themselves during these momentum shifts
iTeos Therapeutics, Inc. Monthly Forecast 2025–2026
October 2025
According to our latest forecast models, iTeos Therapeutics, Inc. (ITOS) is positioned to show a strong performance in October 2025. The price is predicted to move between $14.29 and $16.42, settling at an average of $15.37. This could translate to a +51.43% gain.
November 2025
Based on current market signals, iTeos Therapeutics, Inc. is projected to trend november 2025. We forecast a trading range from $15.44 to $18.98, with a likely average price of $17.36. Investors could expect a potential return of +71.03%.
December 2025
Our predictive algorithms indicate iTeos Therapeutics, Inc. stock may see a shift in December 2025. The expected range spans $14.39–$17.92, with an average target of $16.20. This represents a positive outlook and a possible gain of +59.61%.
January 2026
Analyzing established trends, iTeos Therapeutics, Inc. looks set to move in January 2026. Projections place the stock between $14.42 and $20.45, averaging around $17.60. This suggests a +73.40% gain from current levels.
February 2026
Market indicators suggest iTeos Therapeutics, Inc. could experience notable changes during February 2026. Prices could fluctuate within $14.57 to $20.16, with a midpoint forecast of $17.50. The stock might deliver a +72.41% gain.
March 2026
Forecasting for March 2026, models estimate that iTeos Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $13.35 and $18.31, averaging $16.28. This signals a positive trajectory with potential returns around +60.39%.
April 2026
According to our latest forecast models, iTeos Therapeutics, Inc. (ITOS) is positioned to show a strong performance in April 2026. The price is predicted to move between $13.08 and $19.88, settling at an average of $16.89. This could translate to a +66.40% gain.
May 2026
Based on current market signals, iTeos Therapeutics, Inc. is projected to trend may 2026. We forecast a trading range from $13.77 to $24.60, with a likely average price of $19.26. Investors could expect a potential return of +89.75%.
June 2026
Our predictive algorithms indicate iTeos Therapeutics, Inc. stock may see a shift in June 2026. The expected range spans $14.94–$25.50, with an average target of $21.41. This represents a positive outlook and a possible gain of +110.94%.
July 2026
Analyzing established trends, iTeos Therapeutics, Inc. looks set to move in July 2026. Projections place the stock between $14.98 and $29.73, averaging around $23.16. This suggests a +128.18% gain from current levels.
August 2026
Market indicators suggest iTeos Therapeutics, Inc. could experience notable changes during August 2026. Prices could fluctuate within $15.77 to $30.77, with a midpoint forecast of $24.15. The stock might deliver a +137.93% gain.
ITOS's history of dividends and stock splits also plays a role in long-term investor confidence.